HealthStream (HSTM) PT Raised to $34 at Barclays

Go back to HealthStream (HSTM) PT Raised to $34 at Barclays

HealthStream (HSTM) PT Raised to $29 at Canaccord Genuity

October 23, 2024 7:19 AM EDT

Canaccord Genuity analyst Richard Close raised the price target on HealthStream (NASDAQ: HSTM) to $29.00 (from $28.00) while maintaining a Hold rating.

The analyst comments "HealthStream posted another steady quarter in 3Q. Adj-EBITDA come in ahead of our and Street estimates, though revenue slightly missed. Revenue guidance was lowered $3 million at the midpoint which management attributed to the utilization anomaly of a consumption-based learning product at a large customer discussed last quarter where consumption returned to normalized levels as opposed to the accelerated consumption levels previously expected. With... More